Drug Type siRNA |
Synonyms TDM 812, TDM812 |
Target |
Action inhibitors |
Mechanism RPN2 inhibitors(ribophorin II inhibitors), RNAi(RNA interference) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Phase 1 | Japan | 13 Mar 2015 |





